Nucleotide-Binding Oligomerization Domain Protein 2 Deficiency Enhances Neointimal Formation in Response to Vascular Injury

Objective—Nucleotide-binding oligomerization domain protein 2 (NOD2) stimulates diverse inflammatory responses resulting in differential cellular phenotypes. To identify the role of NOD2 in vascular arterial obstructive diseases, we investigated the expression and pathophysiological role of NOD2 in a vascular injury model of neointimal hyperplasia. Methods and Results—We first analyzed for neointimal hyperplasia following femoral artery injury in NOD2+/+ and NOD2−/− mice. NOD2−/− mice showed a 2.86-fold increase in neointimal formation that was mainly composed of smooth muscle (SM) &agr;-actin positive cells. NOD2 was expressed in vascular smooth muscle cells (VSMCs) and NOD2−/− VSMCs showed increased cell proliferation in response to mitogenic stimuli, platelet-derived growth factor-BB (PDGF-BB), or fetal bovine serum, compared with NOD2+/+ VSMCs. Furthermore, NOD2 deficiency markedly promoted VSMCs migration in response to PDGF-BB, and this increased cell migration was attenuated by a phosphatidylinositol 3-kinase inhibitor. However, protein kinase C and c-Jun N-terminal kinase inhibitors exerted negligible effects. Moreover, muramyl dipeptide–stimulated NOD2 prevented PDGF-BB-induced VSMCs migration. Conclusion—Functional NOD2 was found to be expressed in VSMCs, and NOD2 deficiency promoted VSMCs proliferation, migration, and neointimal formation after vascular injury. These results provide evidence for the involvement of NOD2 in vascular homeostasis and tissue injury, serving as a potential molecular target in the modulation of arteriosclerotic vascular disease.

[1]  A. Davies,et al.  Unexpected protective role for Toll-like receptor 3 in the arterial wall , 2011, Proceedings of the National Academy of Sciences.

[2]  T. Billiar,et al.  Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.

[3]  T. Matsuo,et al.  Proinflammatory effects of muramyldipeptide on human gingival fibroblasts. , 2010, Journal of periodontal research.

[4]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[5]  T. Matsuo,et al.  Roles of TLR2, TLR4, NOD2, and NOD1 in Pulp Fibroblasts , 2009, Journal of dental research.

[6]  Kaoru Tominaga,et al.  Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.

[7]  S. Girardin,et al.  Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes1 , 2008, The Journal of Immunology.

[8]  C. Thiemermann,et al.  Selective NOD1 agonists cause shock and organ injury/dysfunction in vivo. , 2007, American journal of respiratory and critical care medicine.

[9]  M. Deschamps,et al.  No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation. , 2006, Transplantation.

[10]  J. Rosenbaum,et al.  Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. , 2006, Microvascular research.

[11]  D. Simon,et al.  Increased Neointima Formation in Cysteine-Rich Protein 2–Deficient Mice in Response to Vascular Injury , 2005, Circulation research.

[12]  Ryan M. O’Connell,et al.  TLR agonists regulate PDGF‐B production and cell proliferation through TGF‐β/type I IFN crosstalk , 2005, The EMBO journal.

[13]  D. Golenbock,et al.  Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae–Infected Vascular Smooth Muscle Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[14]  P. Tobias,et al.  Modulation of atherosclerosis in mice by Toll-like receptor 2. , 2005, The Journal of clinical investigation.

[15]  C. Jun,et al.  Induction and localization of NOD2 protein in human endothelial cells. , 2005, Cellular immunology.

[16]  Yen-Hsu Chen,et al.  Role of Ets-2 in the Regulation of Heme Oxygenase-1 by Endotoxin* , 2005, Journal of Biological Chemistry.

[17]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Davies,et al.  Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.

[19]  P. Rosenstiel,et al.  TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .

[20]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[21]  G. Kundu,et al.  Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3′-Kinase Activity in Breast Cancer Cells* , 2003, The Journal of Biological Chemistry.

[22]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[23]  J. Sluijter,et al.  In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions , 2002, Circulation.

[24]  Charles A. Janeway,et al.  Decoding the Patterns of Self and Nonself by the Innate Immune System , 2002, Science.

[25]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[26]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[27]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[28]  C. Heldin,et al.  Mechanisms of platelet‐derived growth factor–induced chemotaxis , 2001, International journal of cancer.

[29]  Y. Chao,et al.  Infectious Agents Are Not Necessary for Murine Atherogenesis , 2000, The Journal of experimental medicine.

[30]  J. Badimón,et al.  Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Qingbo Xu,et al.  Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. , 1999, Circulation.

[32]  C. Janeway,et al.  Innate immunity: impact on the adaptive immune response. , 1997, Current opinion in immunology.

[33]  K. Miyazawa,et al.  Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. , 1995, Atherosclerosis.

[34]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.